
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$1.37B
Market Cap
-
P/E Ratio
-2.27
EPS
$42.27
52 Week High
$6.43
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$839K |
| Total Revenue | $0 |
| Cost Of Revenue | $839K |
| Costof Goods And Services Sold | $839K |
| Operating Income | -$83M |
| Selling General And Administrative | $22M |
| Research And Development | $61M |
| Operating Expenses | $82M |
| Investment Income Net | - |
| Net Interest Income | $12M |
| Interest Income | $12M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $839K |
| Income Before Tax | -$78M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$78M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$78M |
| Ebitda | -$77M |
| Net Income | -$78M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$839K |
| Total Revenue | $0 |
| Cost Of Revenue | $839K |
| Costof Goods And Services Sold | $839K |
| Operating Income | -$83M |
| Selling General And Administrative | $22M |
| Research And Development | $61M |
| Operating Expenses | $82M |
| Investment Income Net | - |
| Net Interest Income | $12M |
| Interest Income | $12M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $839K |
| Income Before Tax | -$78M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$78M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$78M |
| Ebitda | -$77M |
| Net Income | -$78M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None